Ligand validation:6GLZ

402: dicarbonyl[bis(cyanide-kappaC)]-mu-(iminodimethanethiolatato-1kappaS:2kappaS)-mu-(oxomethylidene)diiron(2+)

402 is a Ligand Of Interest in 6GLZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6GLZ_402_A_601	64%	1%	0.149	0.949	2.43	5.55	6	1	2	0	100%	0.6441
6GLZ_402_B_601	50%	1%	0.18	0.932	2.35	5.59	6	1	1	0	100%	0.6429
8PVM_402_A_601	98%	5%	0.075	0.995	2.47	2.89	7	1	0	0	100%	0.81
7QHF_402_A_601	96%	9%	0.085	0.995	2.68	1.74	7	1	1	0	100%	1
6N59_402_A_601	94%	22%	0.093	0.995	2.55	0.73	10	-	1	0	100%	0.6494
6N6P_402_A_601	94%	23%	0.084	0.985	2.51	0.71	10	-	0	0	100%	0.9412
4XDC_402_A_601	92%	3%	0.104	0.996	3.49	2.86	8	2	1	0	100%	0.9829
6NAC_402_A_601	92%	28%	0.092	0.983	2.59	0.34	11	-	0	0	100%	0.9541

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.